Research Objectives

 
Stock Quotes for Research Objectives top ^
  • Industry: Software - Application
  • Sector: Technology
  • Stock Style: Small Core
Sign-up for ocl investment picks

 
News Articles for Research Objectives top ^
2014/12/1
OCP Senior Credit Fund Announces Changes to Investment Objectives on or About the Termination of the Forward Agreement on November 19, 2015 Canada NewsWire TORONTO , Dec.
Sign-up for OCP Senior Credit Fund Announces Changes to Investment Objectives on or About the Termination of the Forward Agreement on November 19, 2015 investment picks
2014/9/19
Mackenzie Investments is changing the investment objectives of Mackenzie Canadian Short Term Yield Class Canada NewsWire TORONTO , Sept.
Sign-up for Mackenzie Investments is changing the investment objectives of Mackenzie Canadian Short Term Yield Class investment picks
RGS, a business unit of Avnet, Inc .
Sign-up for RGS Scales Mountains of Big Data with New Object Storage Solution in the Americas investment picks
2014/11/20
By Dominic Chopping STOCKHOLM--Swedish truck maker Volvo AB (VOLV-B.SK) said Thursday that it has received a Statement of Objections from the European Commission, stating the Commission's preliminary view that Volvo and other companies in the truck industry may have breached EU antitrust rules.
Sign-up for Volvo Gets Statement of Objections in Commission's Antitrust Probe investment picks
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that two Phase 3 clinical trials (Studies 104 and 111) evaluating an investigational once-daily single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults met their primary objectives.
Sign-up for Gilead’s Investigational Tenofovir Alafenamide (TAF)-Based Single Tablet HIV Regimen Meets 48-Week Primary Objective in Two Phase 3 Studies investment picks
Liquidity Services, Inc. (NASDAQ: LQDT): Business Realignment Actions Liquidity Services, a global solutions provider in the reverse supply chain with the leading marketplace for business surplus, today announced it has realigned its workforce in response to the new terms and scope of its Department of Defense (DoD) Surplus Contract, competitively bid in April 2014, and to adjust for the efficiencies realized in its commercial business through ongoing integration efforts to support the future vision and growth of the Company.
Sign-up for Liquidity Services Announces Business Realignment Actions and New Senior Leadership Appointments to Support Integration and Growth Objectives investment picks
Bristol-Myers Squibb Company (NYSE:BMY) today announced results from CheckMate -063, a Phase 2 single-arm, open-label study of Opdivo (nivolumab), an investigational PD-1 immune checkpoint inhibitor, administered as a single agent in patients with advanced squamous cell non-small cell lung cancer (NSCLC) who have progressed after at least two prior systemic treatments with 65% receiving three or more prior therapies (n=117). With approximately 11 months of minimum follow up, the objective response rate (ORR, the study’s primary endpoint) was 15% (95% CI = 8.7, 22.2) as assessed by an independent review committee (IRC) using RECIST 1.1 criteria and the median duration of response was not reached.
Sign-up for Phase 2 Objective Response Rate and Survival Data for Opdivo (nivolumab) in Heavily Pre-treated Advanced Squamous Cell Non-Small Cell Lung Cancer to be Presented at the 2014 Chicago Multidisciplinary Symposium on Thoracic Oncology investment picks
2014/12/1
By Sven Grundberg STOCKHOLM--Swedish telecommunications operator TeliaSonera AB (TLSN.SK) is facing hurdles completing the acquisition of Tele2 AB's (TEL2-B.SK) Norwegian telecom operations, as Norway's competition authority has raised objections to the deal.
Sign-up for TeliaSonera: Norwegian Regulator Raises Objections to Tele2 Norway Deal investment picks
2014/10/21
MORRIS TOWNSHIP, N.J. , Oct.
Sign-up for Honeywell Responds To European Commission Statement Of Objections investment picks
2014/9/24
Leiden, The Netherlands, Sept.
Sign-up for Prosensa publishes a sensitive, reproducible and objective methodology for dystrophin analysis in patients with Duchenne muscular dystrophy investment picks
Lilien Systems, a wholly-owned subsidiary of Sysorex Global Holdings Corp.
Sign-up for Lilien Systems Announces New Reseller Partner Agreements with Seagate and Basho for Object Storage Solutions investment picks
Plans to Payout Approximately 60 Percent of Adjusted Net Income on Average to Shareholders Through 2018 Guides to Improved Adjusted Operating Margin of 52-54 Percent by 2018 Reinitiating Share Repurchases With Plans for Approximately $2 Billion Through 2015 Plans to Increase Dividend 30 Percent Beginning 1Q 2015 Expects to Deliver Double-Digit Adjusted Earnings Per Share (EPS) Growth on Average Through 2018 $1.5 Billion in Annual Savings Planned by 2018 Preparing to Launch Four High-Potential Innovative Medicines in 2015 Expands Biosimilars Portfolio to Nine Programs, Total Portfolio Represents a $3 Billion Plus Opportunity Launching Next-Generation Biomanufacturing Technologies in 2017 Provides Preliminary 2015 Guidance of Revenues of $20.8-$21.3 Billion and Adjusted EPS of $9.05-$9.40 NEW YORK , Oct.
Sign-up for Amgen Outlines Strategy, Growth Objectives And Capital Allocation Plans investment picks
2014/12/1
STOCKHOLM--The Norwegian Competition Authority Monday said it is considering blocking TeliaSonera AB's proposed acquisition of Tele2 AB's Norwegian telecom operations.
Sign-up for TeliaSonera: Norwegian Regulator Raises Objections investment picks
2014/12/1
By Sven Grundberg STOCKHOLM--The Norwegian Competition Authority Monday said it is considering blocking TeliaSonera AB's proposed acquisition of Tele2 AB's Norwegian telecom operations.
Sign-up for TeliaSonera: Norwegian Regulator Raises Objections to Tele2 Norway Deal--Update investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Research Objectives
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research Note  |  Next: Research Offers